These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 30854907)

  • 1. Molecular Pathologic Subtyping of Urothelial Bladder Carcinoma in Young Patients.
    Shelekhova KV; Krykow KA; Mescherjakov IA; Mitin NP
    Int J Surg Pathol; 2019 Aug; 27(5):483-491. PubMed ID: 30854907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bladder Tumor Subtype Commitment Occurs in Carcinoma
    Wullweber A; Strick R; Lange F; Sikic D; Taubert H; Wach S; Wullich B; Bertz S; Weyerer V; Stoehr R; Breyer J; Burger M; Hartmann A; Strissel PL; Eckstein M
    Cancer Res; 2021 Mar; 81(6):1552-1566. PubMed ID: 33472889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral Heterogeneity of Bladder Cancer by Molecular Subtypes and Histologic Variants.
    Warrick JI; Sjödahl G; Kaag M; Raman JD; Merrill S; Shuman L; Chen G; Walter V; DeGraff DJ
    Eur Urol; 2019 Jan; 75(1):18-22. PubMed ID: 30266310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors.
    Tan TZ; Rouanne M; Tan KT; Huang RY; Thiery JP
    Eur Urol; 2019 Mar; 75(3):423-432. PubMed ID: 30213523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management.
    Paner GP; Zehnder P; Amin AM; Husain AN; Desai MM
    Adv Anat Pathol; 2011 Jan; 18(1):79-89. PubMed ID: 21169741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
    Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting outcomes in non-muscle invasive (Ta/T1) bladder cancer: the role of molecular grade based on luminal/basal phenotype.
    Rebola J; Aguiar P; Blanca A; Montironi R; Cimadamore A; Cheng L; Henriques V; Lobato-Faria P; Lopez-Beltran A
    Virchows Arch; 2019 Oct; 475(4):445-455. PubMed ID: 31240474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Simple Immunohistochemical Panel Could Predict and Correlate to Clinicopathologic and Molecular Subgroups of Urinary Bladder Urothelial Carcinoma.
    Makboul R; Hassan HM; Refaiy A; Abdelkawi IF; Shahat AA; Hameed DA; Morsy A; Salah T; Ahmed Mohammed RA
    Clin Genitourin Cancer; 2019 Jun; 17(3):e712-e719. PubMed ID: 31085058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of squamous differentiation in urothelial cell carcinoma: a paradigm for molecular subtyping of urothelial cell carcinoma of the bladder.
    Adam RM; DeGraff DJ
    Urol Oncol; 2015 Oct; 33(10):444-50. PubMed ID: 26254697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De Novo Bladder Urothelial Neoplasm in Renal Transplant Recipients: A Retrospective, Multicentered Study.
    Palazzetti A; Bosio A; Dalmasso E; Destefanis P; Fop F; Pisano F; Segoloni G; Biancone L; Volpe A; Di Domenico A; Terrone C; Iesari S; Famulari A; Todeschini P; Frea B; Gontero P
    Urol Int; 2018; 100(2):185-192. PubMed ID: 29342465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.
    Genitsch V; Kollár A; Vandekerkhove G; Blarer J; Furrer M; Annala M; Herberts C; Pycha A; de Jong JJ; Liu Y; Krentel F; Davicioni E; Gibb EA; Kruithof-de Julio M; Wyatt AW; Seiler R
    Urol Oncol; 2019 Nov; 37(11):826-836. PubMed ID: 31585777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IMP3 expression in urothelial carcinomas of the urinary bladder.
    Ozdemir NO; Türk NS; Düzcan E
    Turk Patoloji Derg; 2011 Jan; 27(1):31-7. PubMed ID: 21469424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD103+ Tumor Infiltrating Lymphocytes Predict a Favorable Prognosis in Urothelial Cell Carcinoma of the Bladder.
    Wang B; Wu S; Zeng H; Liu Z; Dong W; He W; Chen X; Dong X; Zheng L; Lin T; Huang J
    J Urol; 2015 Aug; 194(2):556-62. PubMed ID: 25752441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Significance of Squamous Differentiation in Urothelial Carcinoma of the Bladder.
    Minato A; Noguchi H; Tomisaki I; Fukuda A; Kubo T; Nakayama T; Fujimoto N
    Cancer Control; 2018; 25(1):1073274818800269. PubMed ID: 30213195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urothelial cancer of bladder in young versus older adults: clinical and pathological characteristics and outcomes.
    Telli O; Sarici H; Ozgur BC; Doluoglu OG; Sunay MM; Bozkurt S; Eroglu M
    Kaohsiung J Med Sci; 2014 Sep; 30(9):466-70. PubMed ID: 25224770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IMP3 is a biomarker for non-muscle-invasive urothelial carcinoma of the bladder associated with an aggressive phenotype.
    Yang F; Zhou Q; Meng L; Xing N
    Medicine (Baltimore); 2019 Jul; 98(27):e16009. PubMed ID: 31277094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral heterogeneity of surrogate molecular subtypes in urothelial carcinoma in situ of the urinary bladder: implications for prognostic stratification of high-risk non-muscle-invasive bladder cancer.
    Garczyk S; Bischoff F; Schneider U; Golz R; von Rundstedt FC; Knüchel R; Degener S
    Virchows Arch; 2021 Aug; 479(2):325-335. PubMed ID: 33650041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathology of the luminal class of urothelial tumors.
    Bernardo C; Eriksson P; Marzouka NA; Liedberg F; Sjödahl G; Höglund M
    J Pathol; 2019 Nov; 249(3):308-318. PubMed ID: 31232464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urothelial tumors of the urinary bladder in young patients: a clinicopathologic study of 59 cases.
    Stanton ML; Xiao L; Czerniak BA; Guo CC
    Arch Pathol Lab Med; 2013 Oct; 137(10):1337-41. PubMed ID: 24079760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonmuscular Invasive Urothelial Carcinoma of the Bladder in Pediatric and Young Adult Patients: Age-related Outcomes.
    Caione P; Patruno G; Pagliarulo V; Bulotta AL; Salerno A; Diomedi Camassei F; Lastilla G; Gerocarni Nappo S
    Urology; 2017 Jan; 99():215-220. PubMed ID: 27450943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.